Zyla Life Sciences Operating Expenses
Zyla Life Sciences reported Operating Expenses of $87.94 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-03-29
- Zyla Life Sciences operating expenses for the quarter ending 2018-12-31 was $18.34M, a 3.33% increase year-over-year.
- Zyla Life Sciences operating expenses for the quarter ending 2018-09-30 was $30.61M, a 36.12% increase year-over-year.
- Zyla Life Sciences operating expenses for the quarter ending 2018-06-30 was $18.81M, a 32.83% decline year-over-year.
- Zyla Life Sciences operating expenses for the quarter ending 2018-03-31 was $20.18M, a 22.66% decline year-over-year.
- Zyla Life Sciences operating expenses for fiscal 2018 was $87.94M, a 6.78% decline from fiscal 2017.
- Zyla Life Sciences operating expenses for fiscal 2017 was $94.34M, a 3.73% decline from fiscal 2016.
- Zyla Life Sciences operating expenses for fiscal 2016 was $97.99M, a 30.57% increase from fiscal 2015.
- Zyla Life Sciences operating expenses for fiscal 2015 was $75.05M, a 92.15% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2018-12-31 | $18.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $48.95M derived: sum of 2 quarters · filed 2019-03-29 | $67.76M derived: sum of 3 quarters · filed 2019-03-29 | $87.94M 10-K · filed 2019-03-29 |
| 2018-09-30 | $30.61M 10-Q · filed 2018-11-19 | $49.41M derived: sum of 2 quarters · filed 2018-11-19 | $69.60M 10-Q · filed 2018-11-19 | $87.35M derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-06-30 | $18.81M 10-Q · filed 2018-08-09 | $38.99M 10-Q · filed 2018-08-09 | $56.74M derived: sum of 3 quarters · filed 2019-03-29 | $79.23M derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-03-31 | $20.18M 10-Q · filed 2018-05-10 | $37.94M derived: sum of 2 quarters · filed 2019-03-29 | $60.42M derived: sum of 3 quarters · filed 2019-03-29 | $88.42M derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-12-31 | $17.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $40.24M derived: sum of 2 quarters · filed 2019-03-29 | $68.24M derived: sum of 3 quarters · filed 2019-03-29 | $94.34M 10-K · filed 2019-03-29 |
| 2017-09-30 | $22.48M 10-Q · filed 2018-11-19 | $50.48M derived: sum of 2 quarters · filed 2018-11-19 | $76.58M 10-Q · filed 2018-11-19 | $101.34M derived: sum of 4 quarters · filed 2018-11-19 |
| 2017-06-30 | $28.00M 10-Q · filed 2018-08-09 | $54.10M 10-Q · filed 2018-08-09 | $78.85M derived: sum of 3 quarters · filed 2018-08-09 | $107.26M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $26.10M 10-Q · filed 2018-05-10 | $50.85M derived: sum of 2 quarters · filed 2018-05-10 | $79.26M derived: sum of 3 quarters · filed 2018-05-10 | $104.38M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $24.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $53.17M derived: sum of 2 quarters · filed 2018-03-16 | $78.28M derived: sum of 3 quarters · filed 2018-03-16 | $97.99M 10-K · filed 2018-03-16 |
| 2016-09-30 | $28.41M 10-Q · filed 2017-11-08 | $53.53M derived: sum of 2 quarters · filed 2017-11-08 | $73.23M 10-Q · filed 2017-11-08 | $99.09M derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $25.12M 10-Q · filed 2017-08-09 | $44.82M 10-Q · filed 2017-08-09 | $70.68M derived: sum of 3 quarters · filed 2017-08-09 | $87.93M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $19.70M 10-Q · filed 2017-05-10 | $45.56M derived: sum of 2 quarters · filed 2017-05-10 | $62.81M derived: sum of 3 quarters · filed 2017-05-10 | $77.60M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $25.86M 10-K · filed 2017-03-13 | $43.11M derived: sum of 2 quarters · filed 2017-03-13 | $57.89M derived: sum of 3 quarters · filed 2017-03-13 | $75.05M 10-K · filed 2018-03-16 |
| 2015-09-30 | $17.25M 10-K · filed 2017-03-13 | $32.04M derived: sum of 2 quarters · filed 2017-03-13 | $49.18M 10-Q · filed 2016-11-08 | $59.55M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $14.78M 10-K · filed 2017-03-13 | $31.93M 10-Q · filed 2016-08-05 | $42.30M derived: sum of 3 quarters · filed 2017-03-13 | $52.84M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $17.15M 10-K · filed 2017-03-13 | $27.52M derived: sum of 2 quarters · filed 2017-03-13 | $38.06M derived: sum of 3 quarters · filed 2017-03-13 | $50.15M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $10.37M 10-K · filed 2016-03-11 | $20.91M derived: sum of 2 quarters · filed 2016-03-11 | $32.99M derived: sum of 3 quarters · filed 2016-03-11 | $39.06M 10-K · filed 2017-03-13 |
| 2014-09-30 | $10.54M 10-K · filed 2016-03-11 | $22.63M derived: sum of 2 quarters · filed 2016-03-11 | $28.68M 10-Q · filed 2015-11-06 | $33.39M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $12.09M 10-K · filed 2016-03-11 | $18.14M 10-Q · filed 2015-08-07 | $22.85M derived: sum of 3 quarters · filed 2016-03-11 | $25.16M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $6.05M 10-K · filed 2016-03-11 | $10.76M derived: sum of 2 quarters · filed 2016-03-11 | $13.07M derived: sum of 3 quarters · filed 2016-03-11 | $15.38M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $4.71M 10-K · filed 2015-03-16 | $7.02M derived: sum of 2 quarters · filed 2015-03-16 | $9.34M derived: sum of 3 quarters · filed 2015-03-16 | $11.38M 10-K · filed 2016-03-11 |
| 2013-09-30 | $2.31M 10-K · filed 2015-03-16 | $4.63M derived: sum of 2 quarters · filed 2015-03-16 | $6.44M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $2.32M 10-K · filed 2015-03-16 | $4.13M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $1.82M 10-K · filed 2015-03-16 | |||
| 2012-12-31 | $6.50M 10-K · filed 2015-03-16 |